Navidea Biopharmaceuticals, Inc.
NAVB · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,680 | $6,032 | -$1,476 | -$3,483 |
| Dep. & Amort. | $27 | $27 | $28 | $26 |
| Deferred Tax | $0 | $185 | $0 | $0 |
| Stock-Based Comp. | $0 | -$34 | $0 | $0 |
| Change in WC | -$35 | -$1,635 | $779 | $834 |
| Other Non-Cash | $6,864 | $116 | -$1,053 | $189 |
| Operating Cash Flow | -$10,249 | $4,690 | -$1,722 | -$2,433 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$17 | -$65 | -$15 | -$72 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $25 | $0 | -$24 | $0 |
| Investing Cash Flow | $8 | -$65 | -$39 | -$72 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$139 | -$205 | -$201 | -$65 |
| Stock Issued | -$50 | $1,689 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$50 | $1,689 | $0 | -$35 |
| Financing Cash Flow | -$189 | $1,485 | -$201 | -$100 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,279 | $6,110 | -$1,962 | -$2,605 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,144 | $34 | $1,996 | $4,601 |
| End Cash | $3,865 | $6,144 | $34 | $1,996 |
| Free Cash Flow | -$10,265 | $4,625 | -$1,762 | -$2,505 |